EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyperglycemia-Induced Loss of Astrocytic Kir4.1 Is Associated with Increased DNMT1 Activity and Altered AMPK/SIRT1 Signaling

Jadier Colón-Vázquez, Yanitza Hernández-Santiago, Christian J Malpica-Nieves, Nathaly M Rosado-Rivera, Joshua J Navedo-Jackson, Arelys A Angueira-Laureano, Miguel P Méndez-González iD, Yuriy Kucheryavykh, Misty J Eaton, Serguei N Skatchkov iD, David E Rivera-Aponte iD

Cells · 2026

DOI: 10.3390/cells15201906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Jadier Colón-Vázquez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Universidad Central del Caribe, Bayamon, PR 00956, USA. Hauptthemen laut MEDLINE: Astrocytes, DNA (Cytosine-5-)-Methyltransferase 1, AMP-Activated Protein Kinases, Hyperglycemia. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Diabetes Association, NINDS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effects of chronic hyperglycemia on CNS, glial homeostasis and Kir4.1 regulation is poorly understood. Elevated blood glucose levels affect polyamine-sensitive inwardly rectifying potassium channels, Kir4.1, in astrocytes and retinal Müller glial cells. These cells regulate extracellular potassium and clear glutamate, processes supported by Kir4.1. Dysregulation of Kir4.1 channels has been implicated in glutamate toxicity, epilepsy, ataxia, and diabetes-induced neurodegeneration. In this study, we used Tandem Mass Tag Proteomic analysis, Pyrosequencing, SDS-PAGE and Western blot analysis, in whole brain and astrocytic primary cultures in hyperglycemic conditions testing DNMT1 and AMPK activities with RG-108, compound C, and AICAR treatments to investigate how hyperglycemia alters Kir4.1 expression in astrocytes and explored two regulatory mechanisms: (i) DNA methylation mediated by DNA methyltransferase 1 (DNMT-1), which uses S-adenosylmethionine (SAM) as a methyl donor, and (ii) metabolic signaling via the AMPK/SIRT-1 cascade. We found that hyperglycemia (25 mM glucose) (i) increased DNMT-1 protein levels in astrocytes by 1.5–2-fold and (ii) decreased AMPK and (iii) SIRT-1 levels, accompanied by a reduction in Kir4.1 protein expression. Pharmacological inhibition of DNMT-1 with RG-108 decreased DNMT-1 levels and restored Kir4.1. Treatment with AICAR, a selective AMPK activator, rescued SIRT-1 and Kir4.1 expression. In summary, hyperglycemia engages dual regulatory pathways: (i) epigenetic via DNMT-1 and (ii) metabolic via AMPK/SIRT-1, which converge on Kir4.1 downregulation in astrocytes. Therefore, both DNMT-1 inhibition and AMPK activation rescued Kir4.1 expression, suggesting functional support for potassium and glutamate homeostasis and membrane potential stability in glia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesDNA (Cytosine-5-)-Methyltransferase 1AMP-Activated Protein KinasesHyperglycemiaSirtuin 1Signal TransductionPotassium Channels, Inwardly RectifyingAnimalsKcnj10 ChannelMiceDNA MethylationMice, Inbred C57BL

Stichwörter der Autor:innen

AMPKDNA methylationDNMT1Kir4.1SIRT-1astrocytesbraindiabetesdiabetic db/db micehyperglycemiaprimary cell culture

Substanzen

DNA (Cytosine-5-)-Methyltransferase 1AMP-Activated Protein KinasesKcnj10 ChannelSirtuin 1Potassium Channels, Inwardly RectifyingDnmt1 protein, mouseSirt1 protein, mouse

Autor:innen und Institutionen

  • Department of Biochemistry, Universidad Central del Caribe, Bayamon, PR 00956, USA.
  • School of Chiropractic, Universidad Central del Caribe, Bayamon, PR 00956, USA.
  • Department of Physiology, Universidad Central del Caribe, Bayamon, PR 00956, USA.
  • Department of Biochemistry, University of Puerto Rico Medical Science, San Juan, PR 00921, USA.
  • School of Medicine, University of Puerto Rico Medical Science, San Juan, PR 00921, USA.
  • Department of Natural Sciences, University of Puerto Rico, Aguadilla, PR 00603, USA.

ORCID-Profile: Miguel P Méndez-González, Serguei N Skatchkov, David E Rivera-Aponte

Förderung

  • American Diabetes Association
  • NINDS NIH HHS
  • NIGMS NIH HHS
  • NIMHD NIH HHS
  • United States Department of Education
  • U.S. National Science Foundation
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Colón-Vázquez, J., Hernández-Santiago, Y., Malpica-Nieves, C. J., Rosado-Rivera, N. M., Navedo-Jackson, J. J., Angueira-Laureano, A. A., Méndez-González, M. P., Kucheryavykh, Y., Eaton, M. J., Skatchkov, S. N., & Rivera-Aponte, D. E. (2026). Hyperglycemia-Induced Loss of Astrocytic Kir4.1 Is Associated with Increased DNMT1 Activity and Altered AMPK/SIRT1 Signaling. Cells. https://doi.org/10.3390/cells15201906

Vancouver

Colón-Vázquez J, Hernández-Santiago Y, Malpica-Nieves CJ, Rosado-Rivera NM, Navedo-Jackson JJ, Angueira-Laureano AA, et al. Hyperglycemia-Induced Loss of Astrocytic Kir4.1 Is Associated with Increased DNMT1 Activity and Altered AMPK/SIRT1 Signaling. Cells. 2026. doi:10.3390/cells15201906

BibTeX
@article{ColnVzquez2026,
  author = {Colón-Vázquez, Jadier and Hernández-Santiago, Yanitza and Malpica-Nieves, Christian J and Rosado-Rivera, Nathaly M and Navedo-Jackson, Joshua J and Angueira-Laureano, Arelys A and Méndez-González, Miguel P and Kucheryavykh, Yuriy and Eaton, Misty J and Skatchkov, Serguei N and Rivera-Aponte, David E},
  title = {Hyperglycemia-Induced Loss of Astrocytic Kir4.1 Is Associated with Increased DNMT1 Activity and Altered AMPK/SIRT1 Signaling},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15201906}
}
Kostenlos starten →